| 2901 |
Hepatic effects of novel selenazolidine prodrugs of selenocysteine developed as potential cancer chemopreventive agents. |
قسم الكيمياء الدوائية |
2005 |
| 2902 |
Improvement of absorption enhancing effects of n-dodecyl-β-D- maltopyranoside by its colon-specific deliver using chitosan capsules. |
قسم الصيدلانيات |
2005 |
| 2903 |
Improvement of absorption enhancing effects of n-dodecyl-β-D- maltopyranoside by its colon-specific deliver using chitosan capsules. |
قسم الصيدلانيات |
2005 |
| 2904 |
Improvement of absorption enhancing effects of n-dodecyl-β-D- maltopyranoside by its colon-specific deliver using chitosan capsules. |
قسم الصيدلانيات |
2005 |
| 2905 |
Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu1,7]-eel calcitonin in rats. |
قسم الصيدلانيات |
2005 |
| 2906 |
Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu1,7]-eel calcitonin in rats. |
قسم الصيدلانيات |
2005 |
| 2907 |
Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu1,7]-eel calcitonin in rats. |
قسم الصيدلانيات |
2005 |
| 2908 |
Pharmacokinetic analysis of the tissue distribution of octaarginine modified liposomes in mice. |
قسم الصيدلانيات |
2005 |
| 2909 |
Pharmacokinetic considerations in nonviral gene delivery. |
قسم الصيدلانيات |
2005 |
| 2910 |
Pharmacokinetics of controlled release morphine (MST) in patients with liver carcinoma |
|
2005 |